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Fragaria vesca L (Rosaceae), wild strawberry, is commonly found in forests, slopes 
and roadsides. Widely spread across Europe, it can be also found in Korea, Japan, 
North America and Canada [1 ]. The roots are traditionally used as decoction and infu-
sion to treat cough symptoms, urinary tract infections, haemorrhoids, diarrhoea, and 
gout, but also for their tonic, stimulant and diuretic properties. Those bioactive properties 
have been mainly related with the composition in various phenol ic compounds such 
as anthocyanins, proanthocyanidins, flavonols, and derivatives of hydroxycinnamic and 
ellagic acids [2, 3]. As far as we know, there are no reports on the phenolic profile and 
antioxidant activity of F. vesca roots. In the present study, commercial and wild roots 
of this species were submitted to different extraction procedures, aqueous (by infusion 
or decoction) and hydromethanolic, in order to compare their antioxidant potential and 
to establish the individual phenolic profile of each one. Commercial and wild samples 
showed similarities in terms of flavan 3-ols (TF30), with catechin derivatives, mainly 
procyanidins, as major compounds in both samples. The commercial sample presented 
ellagic acid glycosides, whereas the wild sample presented flavonols (TF) and dihydro-
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navonols (taxifolin derivatives). The infusion of wild sample gave the highest content of 
total phenolic compounds (TPC, 253.42 mg/g, dw) and the highest DPPH scavenging 
activity, reducing power and lipid peroxidation inhibition (TSARS assay) (EC50 = 50.56, 
44.78 and 4.76 1-Jg/ml, respectively). The antioxidant capacity (mainly ~-carotene 
bleaching and TSARS assays) observed for the wi ld sample is correlated with TF30 , 
TF and TPC. Overall, the antioxidant activity of F. vesca roots could be directly obtained 
by consumption of infusions/decoctions or by incorporating hydromethanolic extracts in 
antioxidant formulations for cosmetic, pharmaceutical or food industries. 
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The present study is designed to prepare and find the optimum active preparation or 
fraction from Korean Red Ginseng inhibiting matrix metalloproteinase-13 (MMP-13) 
expression [1 ,2], since MMP-13 is a pivotal enzyme to degrade the collagen matrix of 
the joint cartilage [3,4]. From total red ginseng ethanol extract, n-BuOH fraction (total 
ginsenoside-enriched fraction), ginsenoside dial-type-enriched fraction (GDF) and gin-
senoside trial-type-enriched fraction (GTF) were prepared, and ginsenoside diol type-/ 
F4-enriched fraction (GDF/F4) was obtained from Panax ginseng leave extract. When 
their effects on MMP-13 expression were compared, the n-BuOH fraction , GDF, and 
GDF/F4 clearly inhibited MMP-13 expression against IL-1 ~-treated SW1353 cells (hu-
man chondrosarcoma), whereas the total extract and GTF did not. In particular, GDF/ 
F4, the most prominent inhibitor, blocked the activation of p38 mitogen-activated protein 
kinase (p38 MAPK), c-Jun-activated protein kinase (JNK), and signal transducer and ac-
tivator of transcription-1/2 (STAT-1/2) among the signal transcription pathways involved. 
Further, GDF/F4 also inhibited the glycosaminoglycan release from IL-1a-treated rabbit 
cartilage culture (30.6% inhibition at 30 1-1g/ml). Therefore, it is suggested that some 
preparation from Korean Red Ginseng and ginseng leaves, particularly GDF/F4, may 
possess the protective activity against cartilage degradation in joint disorders, and may 
have potential as a new therapeutic agent. 
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